English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Thrombocytopenia is common in cancer patients; it may be secondary to the malignancy itself, its treatment, or other etiologies, such as liver disease or infection. In the absence of any currently effective therapy to prevent thrombocytopenia, the usual clinical response is to decrease the dose and/

The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors